Compile Data Set for Download or QSAR
Report error Found 27 of ph data with Target = 'Cathepsin G'
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113301BDBM113301(US9695194, 17)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113297BDBM113297(US9695194, 14)
Affinity DataKi:  200nM ΔG°:  -39.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113300BDBM113300(US9695194, 16)
Affinity DataKi:  400nM ΔG°:  -38.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113293BDBM113293(US9695194, 10)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113299BDBM113299(US9695194, 15)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113283BDBM113283(US9695194, 8)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113295BDBM113295(US9695194, 12)
Affinity DataKi:  700nM ΔG°:  -36.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113296BDBM113296(US9695194, 13)
Affinity DataKi:  700nM ΔG°:  -36.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113119BDBM113119(US9695194, 6)
Affinity DataKi:  700nM ΔG°:  -36.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113067BDBM113067(US9695194, 3)
Affinity DataKi:  1.10E+3nM ΔG°:  -35.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113069BDBM113069(US9695194, 5)
Affinity DataKi:  1.20E+3nM ΔG°:  -35.2kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113292BDBM113292(US9695194, 9)
Affinity DataKi:  1.30E+3nM ΔG°:  -34.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279766BDBM50279766({2-{5-Benzyloxy-4-[4-(5-benzyloxy-4-hydroxymethyl-...)
Affinity DataKi:  1.50E+3nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113248BDBM113248(US9695194, 7)
Affinity DataKi:  1.90E+3nM ΔG°:  -34.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50289001BDBM50289001(2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazi...)
Affinity DataKi:  1.90E+3nM ΔG°:  -34.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113068BDBM113068(US9695194, 4)
Affinity DataKi:  2.80E+3nM ΔG°:  -33.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113060BDBM113060(US9695194, 1)
Affinity DataKi: >1.00E+4nM ΔG°: >-29.7kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113065BDBM113065(US9695194, 2)
Affinity DataKi: >1.00E+4nM ΔG°: >-29.7kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 113294BDBM113294(US9695194, 11)
Affinity DataKi: >1.00E+4nM ΔG°: >-29.7kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50060329BDBM50060329({2-{4-[5-Carboxymethoxy-4-(5-hydroxy-2-methoxy-4-m...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50060330BDBM50060330({5-[4-(2-Carboxymethoxy-5-methoxy-benzyl)-5-methox...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279767BDBM50279767({5-[4-(2-Carboxymethoxy-5-methoxy-benzyl)-5-methox...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279770BDBM50279770(2-{4-benzyloxy-5-[5-benzyloxy-4-(5-benzyloxy-4-{5-...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279768BDBM50279768((2-{2-Benzyloxy-4-[2-benzyloxy-4-(2-benzyloxy-5-ca...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279771BDBM50279771([4-Benzyloxy-5-{5-benzyloxy-4-[5-benzyloxy-2-carbo...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50060332BDBM50060332(CHEMBL215927)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin G(Human)
Sixera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50279765BDBM50279765({2-{4-[5-Carboxymethoxy-4-(5-cyclohexylmethoxy-2-m...)
Affinity DataKi: >1.50E+4nMpH: 7.5Assay Description:Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed